Geron Corp. (NASDAQ: GERN) on Monday, soared 0.44% from the previous trading day, before settling in for the closing price of $4.54. Within the past 52 weeks, GERN’s price has moved between $1.64 and $5.34.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 46.26% annually for the last half of the decade. The company achieved an average annual earnings per share of -9.51%. With a float of $551.75 million, this company’s outstanding shares have now reached $602.80 million.
In an organization with 141 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -2113.26%, operating margin of -16559.94%, and the pretax margin is -15990.68%.
Geron Corp. (GERN) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Geron Corp. is 8.47%, while institutional ownership is 69.60%. The most recent insider transaction that took place on Jul 08 ’24, was worth 3,073,004. In this transaction EVP, Chief Operating Officer of this company sold 674,348 shares at a rate of $4.56, taking the stock ownership to the 0 shares. Before that another transaction happened on Jun 10 ’24, when Company’s EVP, Chief Medical Officer sold 287,900 for $4.63, making the entire transaction worth $1,334,129. This insider now owns 0 shares in total.
Geron Corp. (GERN) Latest Financial update
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.08 earnings per share (EPS) for the period topping the consensus outlook (set at -0.1) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -9.51% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.00% during the next five years compared to -16.08% drop over the previous five years of trading.
Geron Corp. (NASDAQ: GERN) Trading Performance Indicators
Geron Corp. (GERN) is currently performing well based on its current performance indicators. A quick ratio of 3.60 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2006.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.36, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.15 in one year’s time.
Technical Analysis of Geron Corp. (GERN)
Let’s dig in a bit further. During the last 5-days, its volume was 5.92 million. That was inferior than the volume of 11.12 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 44.17%. Additionally, its Average True Range was 0.21.
During the past 100 days, Geron Corp.’s (GERN) raw stochastic average was set at 64.46%, which indicates a significant increase from 56.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 29.29% in the past 14 days, which was lower than the 59.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.58, while its 200-day Moving Average is $3.19. However, in the short run, Geron Corp.’s stock first resistance to watch stands at $4.62. Second resistance stands at $4.68. The third major resistance level sits at $4.76. If the price goes on to break the first support level at $4.49, it is likely to go to the next support level at $4.41. The third support level lies at $4.35 if the price breaches the second support level.
Geron Corp. (NASDAQ: GERN) Key Stats
Market capitalization of the company is 2.75 billion based on 593,133K outstanding shares. Right now, sales total 240 K and income totals -184,130 K. The company made 880 K in profit during its latest quarter, and -67,380 K in sales during its previous quarter.
